Submission Details
| 510(k) Number | K233594 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 08, 2023 |
| Decision Date | December 13, 2023 |
| Days to Decision | 35 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K233594 is an FDA 510(k) clearance for the Genesys Spine 3DP AIS-C II Cervical Interbody System. This device is classified as a Intervertebral Fusion Device With Integrated Fixation, Cervical (Class II — Special Controls, product code OVE).
Submitted by Genesys Spine (Austin, US). The FDA issued a Cleared decision on December 13, 2023, 35 days after receiving the submission on November 8, 2023.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation..
| 510(k) Number | K233594 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 08, 2023 |
| Decision Date | December 13, 2023 |
| Days to Decision | 35 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | OVE — Intervertebral Fusion Device With Integrated Fixation, Cervical |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation. |